NuVision are excited to announce the launch of our latest innovation, OmniLenz, which was showcased at the British Emergency Eye Care Society (BEECS) meeting recently.

23703 NuVision OmniLenz Logo

Screen Shot 2017-10-12 at 17.07.08

1This now enables human ophthalmologists to simply access versatile ‘off-the-shelf’ regenerative therapy that can be applied in theatre, in the clinic and even in emergency situations at the point-of-care, or in the field.

Patients may benefit from treatment earlier and therefore potentially more effectively, from first presentation. With OmniLenz application of Omnigen, NuVision aims to dramatically shorten the treatment pathway to improve patient care whilst saving NHS theatre time and therefore money.

OmniLenz is manufactured exclusively for NuVision in the UK by Menicon Limited, utilising the tried and tested comfort and safety of an established Menicon Soft 72 contact lens worn daily by the general public. The first version, OmniLenz C, is designed for the application of Omnigen 80 (10 mm disc) to treat central corneal defects.

Developed through Innovate UK Biomedical Catalysts funding, OmniLenz may revolutionise the treatment approach for corneal disorders in human patients. The lens is easy to apply and remove, with the concept proven during trial stages, where it was well tolerated at the ocular surface long-term.

“OmniLenz was designed to deliver Omnigen as a simple and cost effective, early intervention preventative therapy for a variety of ocular surface conditions. OmniLenz has made treating devastating ocular surface defects as easy as applying a contact lens” said Dr Andrew Hopkinson, CEO.

5“The simplicity of using OmniLenz to apply Omnigen means that Omnigen can be applied directly to the surface of the eye without the need for multifaceted surgery. It allows patients to be treated quickly in the clinic r in situations where surgery is not accessible or unavailable” said Dr Emily Britchford, Research and Development manager at NuVision.

We are confident that OmniLenz will be hugely beneficial in clinics ensuring Omnigen regeneration is delivered to the patient comfortably and efficiently.